Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.
New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for an undisclosed Pfizer drug, adding 13% to its shares value on Nasdaq.
Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosi
The US Food and Drug Administration has approved an over-the-air software upgrade for Infinity implants manufactured by Abbott, giving devices used in Parkinson’s and essential tremor full-
